LAURA PEREZ: Open Payments
NPI 1700138625 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 38 payments from 14 companies in 2025. Trend: 2023 $1,035 · 2024 $1,332 · 2025 $897
Food & beverage: $787Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $197 |
| ABBVIE INC. | 13 | $188 |
| UCB, Inc. | 3 | $102 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Lilly USA, LLC | 2 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| GENZYME CORPORATION | 1 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $30 |
| Incyte Corporation | 1 | $24 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, TALTZ, ILUMYA, RINVOQ, LIBTAYO.
Industry payments across FL — which companies pay providers there.
